DGX logo

DGX Cash and cash equivalents

annual cash & cash equivalents:

$549.00M-$137.00M(-19.97%)
December 31, 2024

Summary

  • As of today (June 2, 2025), DGX annual cash & cash equivalents is $549.00 million, with the most recent change of -$137.00 million (-19.97%) on December 31, 2024.
  • During the last 3 years, DGX annual cash & cash equivalents has fallen by -$323.00 million (-37.04%).
  • DGX annual cash & cash equivalents is now -53.94% below its all-time high of $1.19 billion, reached on December 31, 2019.

Performance

DGX Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXbalance sheet metrics

quarterly cash & cash equivalents:

$188.00M-$361.00M(-65.76%)
March 31, 2025

Summary

  • As of today (June 2, 2025), DGX quarterly cash & cash equivalents is $188.00 million, with the most recent change of -$361.00 million (-65.76%) on March 31, 2025.
  • Over the past year, DGX quarterly cash & cash equivalents has dropped by -$286.00 million (-60.34%).
  • DGX quarterly cash & cash equivalents is now -88.29% below its all-time high of $1.60 billion, reached on September 30, 2020.

Performance

DGX quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDGXbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

DGX Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-20.0%-60.3%
3 y3 years-37.0%-73.6%
5 y5 years-53.9%-45.0%

DGX Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-37.0%+74.3%-76.2%+49.2%
5 y5-year-53.9%+74.3%-88.3%+49.2%
alltimeall time-53.9%+1912.2%-88.3%+589.0%

DGX Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$188.00M(-65.8%)
Dec 2024
$549.00M(-20.0%)
$549.00M(-28.1%)
Sep 2024
-
$764.00M(+181.9%)
Jun 2024
-
$271.00M(-42.8%)
Mar 2024
-
$474.00M(-30.9%)
Dec 2023
$686.00M(+117.8%)
$686.00M(+379.7%)
Sep 2023
-
$143.00M(+13.5%)
Jun 2023
-
$126.00M(-28.0%)
Mar 2023
-
$175.00M(-44.4%)
Dec 2022
$315.00M(-63.9%)
$315.00M(-55.0%)
Sep 2022
-
$700.00M(-11.4%)
Jun 2022
-
$790.00M(+11.0%)
Mar 2022
-
$712.00M(-18.3%)
Dec 2021
$872.00M(-24.7%)
$872.00M(-11.7%)
Sep 2021
-
$987.00M(+76.3%)
Jun 2021
-
$560.00M(-54.5%)
Mar 2021
-
$1.23B(+6.2%)
Dec 2020
$1.16B(-2.9%)
$1.16B(-27.9%)
Sep 2020
-
$1.60B(+62.4%)
Jun 2020
-
$988.00M(+188.9%)
Mar 2020
-
$342.00M(-71.3%)
Dec 2019
$1.19B(+783.0%)
$1.19B(+174.7%)
Sep 2019
-
$434.00M(+59.0%)
Jun 2019
-
$273.00M(-41.2%)
Mar 2019
-
$464.00M(+243.7%)
Dec 2018
$135.00M(-1.5%)
$135.00M(-48.7%)
Sep 2018
-
$263.00M(+99.2%)
Jun 2018
-
$132.00M(+6.5%)
Mar 2018
-
$124.00M(-9.5%)
Dec 2017
$137.00M(-61.8%)
$137.00M(-60.9%)
Sep 2017
-
$350.00M(+11.5%)
Jun 2017
-
$314.00M(-14.4%)
Mar 2017
-
$367.00M(+2.2%)
Dec 2016
$359.00M(+169.9%)
$359.00M(-11.6%)
Sep 2016
-
$406.00M(+43.5%)
Jun 2016
-
$283.00M(+121.1%)
Mar 2016
-
$128.00M(-3.8%)
Dec 2015
$133.00M(-30.7%)
$133.00M(+8.1%)
Sep 2015
-
$123.00M(-18.0%)
Jun 2015
-
$150.00M(-84.6%)
Mar 2015
-
$974.00M(+407.3%)
Dec 2014
$192.00M(+2.7%)
$192.00M(+12.9%)
Sep 2014
-
$170.00M(+18.1%)
Jun 2014
-
$144.00M(0.0%)
Mar 2014
-
$144.00M(-23.0%)
Dec 2013
$187.00M(-36.8%)
$187.00M(+18.1%)
Sep 2013
-
$158.28M(+6.7%)
Jun 2013
-
$148.34M(+11.0%)
Mar 2013
-
$133.60M(-54.9%)
Dec 2012
$296.00M(+79.5%)
$296.00M(+54.4%)
Sep 2012
-
$191.77M(+10.4%)
Jun 2012
-
$173.74M(+19.5%)
Mar 2012
-
$145.44M(-11.8%)
Dec 2011
$164.89M
$164.89M(+48.8%)
Sep 2011
-
$110.83M(-39.8%)
Jun 2011
-
$184.22M(-81.5%)
DateAnnualQuarterly
Mar 2011
-
$994.24M(+121.3%)
Dec 2010
$449.30M(-15.9%)
$449.30M(+0.3%)
Jun 2010
-
$447.89M(-3.3%)
Mar 2010
-
$463.24M(-13.3%)
Dec 2009
$534.26M(+110.4%)
$534.26M(+116.3%)
Sep 2009
-
$247.03M(+107.1%)
Jun 2009
-
$119.29M(-41.6%)
Mar 2009
-
$204.22M(-19.6%)
Dec 2008
$253.95M(+51.5%)
$253.95M(-11.4%)
Sep 2008
-
$286.68M(+99.9%)
Jun 2008
-
$143.40M(-15.7%)
Mar 2008
-
$170.02M(+1.4%)
Dec 2007
$167.59M(+12.0%)
$167.59M(+1.8%)
Sep 2007
-
$164.62M(+34.6%)
Jun 2007
-
$122.30M(-22.8%)
Mar 2007
-
$158.40M(+5.9%)
Dec 2006
$149.64M(+62.4%)
$149.64M(+42.4%)
Sep 2006
-
$105.11M(-30.2%)
Jun 2006
-
$150.68M(-3.7%)
Mar 2006
-
$156.46M(+69.8%)
Dec 2005
$92.13M(+25.7%)
$92.13M(-56.1%)
Sep 2005
-
$210.09M(+2.9%)
Jun 2005
-
$204.11M(+136.9%)
Mar 2005
-
$86.16M(+17.5%)
Dec 2004
$73.30M(-52.7%)
$73.30M(-63.5%)
Sep 2004
-
$201.04M(+45.9%)
Jun 2004
-
$137.80M(-27.5%)
Mar 2004
-
$190.07M(+22.7%)
Dec 2003
$154.96M(+60.1%)
$154.96M(+70.2%)
Sep 2003
-
$91.07M(+3.4%)
Jun 2003
-
$88.07M(+58.4%)
Mar 2003
-
$55.60M(-42.6%)
Dec 2002
$96.78M(-20.9%)
$96.78M(-15.0%)
Sep 2002
-
$113.85M(+26.7%)
Jun 2002
-
$89.84M(-39.9%)
Mar 2002
-
$149.43M(+22.1%)
Dec 2001
$122.33M(-28.7%)
$122.33M(-48.8%)
Sep 2001
-
$238.88M(+37.2%)
Jun 2001
-
$174.16M(+44.3%)
Mar 2001
-
$120.73M(-29.6%)
Dec 2000
$171.48M(+528.5%)
$171.48M(+6.0%)
Sep 2000
-
$161.79M(+62.7%)
Jun 2000
-
$99.43M(+249.0%)
Mar 2000
-
$28.49M(+4.4%)
Dec 1999
$27.28M(-86.6%)
$27.28M(-25.9%)
Sep 1999
-
$36.80M(-75.2%)
Jun 1999
-
$148.50M(-3.7%)
Mar 1999
-
$154.20M(-24.0%)
Dec 1998
$202.90M(+25.5%)
$202.90M(+12.1%)
Sep 1998
-
$181.00M(+18.5%)
Jun 1998
-
$152.70M(-11.5%)
Mar 1998
-
$172.60M(+6.7%)
Dec 1997
$161.70M(+285.4%)
$161.70M(+29.9%)
Sep 1997
-
$124.50M(+64.2%)
Jun 1997
-
$75.80M(+11.6%)
Mar 1997
-
$67.90M
Dec 1996
$41.96M
-

FAQ

  • What is Quest Diagnostics Incorporated annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated annual cash & cash equivalents year-on-year change?
  • What is Quest Diagnostics Incorporated quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated quarterly cash & cash equivalents year-on-year change?

What is Quest Diagnostics Incorporated annual cash & cash equivalents?

The current annual cash & cash equivalents of DGX is $549.00M

What is the all time high annual cash & cash equivalents for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high annual cash & cash equivalents is $1.19B

What is Quest Diagnostics Incorporated annual cash & cash equivalents year-on-year change?

Over the past year, DGX annual cash & cash equivalents has changed by -$137.00M (-19.97%)

What is Quest Diagnostics Incorporated quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of DGX is $188.00M

What is the all time high quarterly cash & cash equivalents for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high quarterly cash & cash equivalents is $1.60B

What is Quest Diagnostics Incorporated quarterly cash & cash equivalents year-on-year change?

Over the past year, DGX quarterly cash & cash equivalents has changed by -$286.00M (-60.34%)
On this page